FDA Drug Recalls

Recalls / Class III

Class IIID-0035-2016

Product

TopCare LORATIDINE ORALLY DISINTEGRATING TABLETS, , USP, 10 mg, packaged in a) Children's 10-count tablets per box (NDC 36800-528-69, UPC 0 3680010261 3); and b) 10-count tablets per box, (NDC 36800-527-69, UPC 0 3680008395 0); Distributed by Topco Associates, LLC, Elk Grove Village, IL 60007.

Affected lot / code info
Batch Numbers: a) 2600127, Exp 2/29/2016; 2617892, Exp 5/31/2016; 2644265, 9/30/2016; 2625092, Exp, 6/30/2016; 2658140, Exp 11/30/2016. b) 2617892, Exp 5/31/2016; 2610783, 4/30/2016; 2644272, Exp 9/30/2016

Why it was recalled

Superpotent Drug: Out Of Specification (OOS) result for Assay.

Recalling firm

Firm
Ohm Laboratories, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1385 Livingston Ave, N/A, North Brunswick, New Jersey 08902-1829

Distribution

Quantity
53,688 boxes
Distribution pattern
Nationwide.

Timeline

Recall initiated
2015-07-28
FDA classified
2015-10-15
Posted by FDA
2015-10-21
Terminated
2016-10-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0035-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.